Acadia Healthcare Company Inc
$ 35.61
3.43%
21 Jul - close price
- Market Cap 3,274,946,000 USD
- Current Price $ 35.61
- High / Low $ 35.65 / 34.23
- Stock P/E N/A
- Book Value 21.58
- EPS -12.20
- Next Earning Report 2026-07-28
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE -0.41 %
- 52 Week High 35.64
- 52 Week Low 11.43
About
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$32.21
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-29 | 2026-02-25 | 2025-11-05 | 2025-08-05 | 2025-05-12 | 2025-02-27 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-27 | 2023-11-02 | 2023-07-27 |
| Reported EPS | 0.37 | 0.07 | 0.72 | 0.83 | 0.4 | 0.64 | 0.91 | 0.91 | 0.84 | 0.85 | 0.91 | 0.92 |
| Estimated EPS | 0.26 | 0.1 | 0.67 | 0.71 | 0.36 | 0.7146 | 0.9 | 0.88 | 0.8 | 0.79 | 0.89 | 0.86 |
| Surprise | 0.11 | -0.03 | 0.05 | 0.12 | 0.04 | -0.0746 | 0.01 | 0.03 | 0.04 | 0.06 | 0.02 | 0.06 |
| Surprise Percentage | 42.3077% | -30% | 7.4627% | 16.9014% | 11.1111% | -10.4394% | 1.1111% | 3.4091% | 5% | 7.5949% | 2.2472% | 6.9767% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-28 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.33 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ACHC
2026-07-21 03:33:31
This article provides a bond profile for ACHC5055371, Acadia Healthcare Company, Inc.'s 5.0% bond maturing on April 15, 2029. It details key metrics such as the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. The profile also includes a brief description of Acadia Healthcare Co., Inc.'s behavioral healthcare services.
2026-07-20 15:41:29
Acadia Healthcare (ACHC) was moved from the Russell 1000 to the Russell 2000 Index, recategorizing it into the smaller-capitalization value universe. This shift is primarily technical, influencing its investor base and trading liquidity, but its impact on the company's fundamentals is less significant than operational execution and reimbursement policy changes. The return of CEO Debra Osteen is highlighted as a more crucial factor for addressing startup losses, legal costs, and Medicaid exposure as the company navigates its new market position.
2026-07-20 15:41:29
Acadia Healthcare Company (ACHC) presented at the 44th Annual J.P. Morgan Healthcare Conference, outlining its strategic vision, operational progress, and financial performance. The company emphasized its growth through new facility openings, workforce development, and technology investments, while reiterating its 2025 financial guidance. Despite some challenges like higher professional liability costs and Medicaid volume softness, ACHC projects significant incremental EBITDA opportunities from new bed additions and expects CapEx to decline in 2026.
2026-07-20 15:40:31
Acadia Healthcare Company (ACHC) has released its proxy filing summary for the annual meeting scheduled for May 6, 2026. Key proposals include electing three Class III directors, amending the incentive compensation plan to increase available shares, holding a non-binding advisory vote on executive compensation, and ratifying Ernst & Young LLP as auditor. The board recommends shareholders vote in favor of all proposals and emphasizes the use of a notice and access model for proxy materials to encourage electronic delivery.
2026-07-20 15:40:31
Acadia Healthcare Company (ACHC) presented at Barclays' 28th Annual Global Healthcare Conference, highlighting leadership changes and an energized focus on patient care and operational execution, including filling 3,000 new beds. The company detailed a $200 million embedded EBITDA opportunity from underperforming new facilities due to licensure delays, aiming for improved utilization and 4% volume growth by 2026. They also addressed strong demand contrasted with challenges from a New York Medicaid policy change expected to cause a $25–$30 million EBITDA headwind in 2026, alongside increased payer scrutiny affecting bad debts.
2026-07-19 22:11:24
Acadia Healthcare Company (ACHC) presented its strategic vision, operational progress, and financial performance at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. The company operates 277 facilities and focuses on high-quality care, access expansion, and technology. Despite challenges like higher professional liability costs and payer pressure, ACHC reiterates its 2025 guidance and projects over $200 million in incremental EBITDA from new facility openings.
